• Title/Summary/Keyword: White rose petal extract

Search Result 2, Processing Time 0.017 seconds

Enhancing the Antioxidant Activities of Wines by Addition of White Rose Extract

  • Seong, Hyunbin;Heo, Jieun;Lee, Kyun Hee;Lee, Yoon Bok;Kim, Yun Bae;Han, Nam Soo
    • Journal of Microbiology and Biotechnology
    • /
    • v.27 no.9
    • /
    • pp.1602-1608
    • /
    • 2017
  • White rose petal extract (WRE) contains large amounts of phenolic compounds and is considered edible. In this study, red and white wines were prepared by the addition of WRE (0.10% or 0.25% (w/v)), followed by fermentation at $25^{\circ}C$ for 15 days. The fermentation profiles, colors, sensory test results, and antioxidant activities of the wines were compared. As reported herein, the fermentation profiles of the pH, $CO_2$ production rate, and final ethanol concentration were not affected by the addition of WRE, but a slow consumption rate of sugar was observed in 0.25% WRE-added wine. In contrast, the total polyphenol concentrations in WRE-added wines increased significantly (p < 0.05) in a dose-dependent manner, resulting in appreciable enhancement of the antioxidant activities of the wines. Chromaticity tests showed slight changes in the redness and yellowness, but sensory tests showed that the overall flavor qualities of the WRE-added wines were acceptable to the panels. This study demonstrates that addition of WRE to wine confers beneficial health effects and this treatment results in better outcome in white wine.

Neuroprotective Effects of a Butanol Fraction of Rosa hybrida Petals in a Middle Cerebral Artery Occlusion Model

  • Yang, Goeun;Park, Dongsun;Lee, Sun Hee;Bae, Dae-Kwon;Yang, Yun-Hui;Kyung, Jangbeen;Kim, Dajeong;Choi, Ehn-Kyoung;Hong, Jin Tae;Jeong, Heon-Sang;Kim, Hee Jung;Jang, Su Kil;Joo, Seong Soo;Kim, Yun-Bae
    • Biomolecules & Therapeutics
    • /
    • v.21 no.6
    • /
    • pp.454-461
    • /
    • 2013
  • The neuroprotective effects of a butanol fraction of white rose petal extract (WRPE-BF) were investigated in a middle cerebral artery occlusion (MCAO) model. Seven week-old male rats were orally administered WRPE-BF for 2 weeks and subjected to MCAO for 2 h, followed by reperfusion. Twenty-four h later, MCAO-induced behavioral dysfunctions were markedly improved in a dose-dependent manner by pretreatment with WRPE-BF. Moreover, higher dose of WRPE-BF not only decreased infarction area but also effectively reduced astrogliosis. The expression of inducible nitric oxide synthase, cyclooxygenase-2, and glial fibrillary acidic protein in MCAO model were markedly inhibited by WRPE-BF treatment. Notably, WRPE-BF decreased nitricoxide and malondialdehyde levels in the striatum and subventricular zone of stroke-challenged brains. These data suggested that WRPE-BF may exert its neuroprotective effects via anti-oxidative and anti-inflammatory activities against ischemia-reperfusion brain injury and could be a good candidate as a therapeutic target for ischemic stroke.